SCHEMBL3050846

SCHEMBL3050846

COc1ccc(N(C)C2CCN(C(=O)c3cc4cc(Oc5ccc(N(C)C(=O)c6ccc(C(F)(F)F)cc6)cn5)ccc4n3C)CC2)cc1.CS(=O)(=O)O

nearest known ligand 0.47

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
PIK3CA known ✓ P42336 1/20 0.42
SCN9A Q15858 17/20 0.47
STAT3 P40763 1/20 0.43
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
PRKAA2 P54646 1/20 0.42
SCN7A Q01118 1/20 0.42
KCNH2 Q12809 1/20 0.42
SCN5A Q14524 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10182042 0.90 STAT3 (0.45) SCN9ASTAT3MAPTHTTPIK3CA
SCHEMBL3067943 0.89 MAPT (0.53) SCN9ASTAT3MAPTHTTPIK3CA
SCHEMBL3062240 0.89 MAPT (0.46) SCN9ASTAT3MAPTHTTPIK3CA
Oxalic Acid SCHEMBL3069686 0.87 STAT3 (0.46) SCN9ASTAT3MAPTHTTPIK3CA
SCHEMBL3059171 0.86 STAT3 (0.46) SCN9ASTAT3MAPTHTTPIK3CA
SCHEMBL10180521 0.86 STAT3 (0.46) SCN9ASTAT3MAPTHTTPIK3CA
SCHEMBL10181050 0.85 STAT3 (0.59) STAT3PIK3CAPRKAA2
Oxalic Acid SCHEMBL3069689 0.85 STAT3 (0.44) SCN9ASTAT3MAPTHTTPIK3CA
SCHEMBL3055461 0.84 SCN9A (0.54) SCN9ASTAT3SCN7AKCNH2SCN5A
SCHEMBL3062169 0.83 SCN9A (0.47) SCN9ASTAT3SCN7AKCNH2SCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8551999-B2 Heterocyclic compound and pharmaceutical composition thereof OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-10-08 US disclosed
EP-2207773-B1 HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF OTSUKA PHARMA CO LTD (JP) 2012-07-11 EP disclosed
US-20100261720-A1 HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100261720-A1 HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF COL1A1, COL2A1, COL14A1 PIK3CA 3582/4885SCN9A 2616/4885STAT3 1499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.